• Self-Amplifying RNA Vaccines Show Durable, Cross-Subtype Inf

  2026-07-27

  This study systematically compares mRNA, self-amplifying RNA (saRNA), and circular RNA vaccine platforms for seasonal influenza, revealing that saRNA vaccines provide robust, long-lasting immunity at ultra-low doses against multiple influenza subtypes, including challenging influenza B strains. The findings address key limitations of current mRNA vaccine platforms and inform design of next-generation RNA vaccines.

• Aurora A Kinase Orchestrates Trained Immunity via SAM Metabo

  2026-07-26

  Li et al. reveal a previously unrecognized role for Aurora kinase A in the regulation of trained immunity, linking its activity to S-adenosylmethionine (SAM) metabolism and epigenetic remodeling. This work advances our understanding of how metabolic-epigenetic crosstalk, orchestrated by Aurora A, sustains innate immune memory and has implications for therapeutic targeting in cancer biology and immunology.

• Irinotecan (CPT-11): Mechanistic Insights and Gut–Liver Axis

  2026-07-25

  Discover how Irinotecan (CPT-11) not only induces DNA damage and apoptosis in colorectal cancer models, but also impacts the gut–liver axis, with practical guidance for translational research. Explore new mechanistic findings and protocol optimizations that distinguish this cornerstone analysis.

• Disodium Bicinchoninate: Advanced Workflows in Biochemical A

  2026-07-24

  Disodium bicinchoninate empowers researchers with a highly water-soluble, interference-resistant chelating agent for modern biochemical and molecular biology workflows. Its superior aqueous solubility and high purity, as supplied by APExBIO, enable robust assay design where traditional reagents fall short. Discover how to leverage this compound for streamlined protocols and reproducibility in demanding applications.

• Decoding Cell Fate: AO/PI Double Staining in Translational R

  2026-07-24

  This article delivers mechanistic clarity and strategic guidance for translational researchers tackling cell death pathway analysis. Leveraging the AO/PI Double Staining Kit, the discussion bridges molecular rationale, experimental validation, and workflow optimization—highlighting recent evidence in cancer therapy and positioning the technology for next-generation translational impact.

• Enhanced Lysosomal Exocytosis Drives Cartilage Pathology in

  2026-07-23

  This study reveals that increased lysosomal exocytosis and altered growth factor signaling are central to cartilage pathology in a zebrafish model of mucopolysaccharidosis type IVA (MPS IVA). By dissecting mechanisms beyond substrate accumulation, the research highlights new cellular processes contributing to skeletal disease and offers avenues for refining lysosome-focused experimental approaches.

• WP1066, JAK2/STAT3 Inhibitor: Advanced Workflows in Cancer &

  2026-07-23

  WP1066 enables precise inhibition of JAK2/STAT3, unlocking translational workflows in cancer biology and bone defect regeneration. Discover actionable protocols, troubleshooting insights, and the reference-driven innovations that distinguish this cell-permeable small molecule.

• NU7441 (KU-57788): Elevating DNA Repair Research Workflows

  2026-07-22

  NU7441 (KU-57788) is a benchmark DNA-PK inhibitor that empowers precise DNA repair and oncology research. Its selectivity and nanomolar potency enable reproducible DNA damage response assays and advanced therapeutic modeling.

• Z-IETD-FMK: Precision Caspase-8 Inhibition in Apoptosis Rese

  2026-07-22

  Z-IETD-FMK (Benzyloxycarbonyl-Ile-Glu(OMe)-Thr-Asp(OMe)-fluoromethylketone) empowers researchers to dissect caspase-8-dependent apoptosis and immune cell signaling with unprecedented specificity. This guide distills advanced workflow enhancements, troubleshooting strategies, and novel insights from recent functional genomics to maximize the translational impact of APExBIO’s trusted caspase-8 inhibitor.

• Cepharanthine: Benchmarks for Apoptosis and Immunomodulation

  2026-07-21

  Cepharanthine, a biscoclaurine alkaloid, demonstrates significant efficacy as an apoptosis inducer and immunomodulator across disease models. Its antitumor and anti-inflammatory actions are supported by robust in vitro and in vivo evidence, with precise molecular mechanisms and a well-defined IC50 profile. APExBIO’s high-purity Cepharanthine enables reproducible studies in apoptosis research and chemotherapy side effect mitigation.

• 10 mM dNTP Mixture: Precision DNA Synthesis for Modern Workf

  2026-07-21

  The 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture from APExBIO offers unmatched consistency and stability for advanced PCR, DNA sequencing, and nucleic acid delivery protocols. Its equimolar formulation directly streamlines setup, boosts reproducibility, and empowers troubleshooting across both routine and cutting-edge molecular biology applications.

• CBD Attenuates Orofacial Inflammatory Pain via Endocannabino

  2026-07-20

  This study demonstrates that cannabidiol (CBD) significantly reduces both sensory and affective symptoms of acute and chronic orofacial inflammatory pain in mice. The findings reveal distinct peripheral and central mechanisms, primarily involving endocannabinoid and serotonergic system modulation, with translational potential for comprehensive pain management.

• MLN4924: NEDD8-Activating Enzyme Inhibitor in Cancer Researc

  2026-07-20

  MLN4924, a highly selective NEDD8-activating enzyme inhibitor, transforms cancer biology research by enabling precise dissection of neddylation and ubiquitin-proteasome dynamics. This article translates the latest mechanistic findings and practical troubleshooting tips into actionable workflows, empowering researchers to maximize MLN4924’s impact in tumor metabolism and protein degradation studies.

• Asymmetric Cu Single-Atom Nanozyme Modulates AMI Inflammatio

  2026-07-19

  This study introduces a bromine-doped, asymmetrically coordinated copper single-atom nanozyme (Cu-BrN3/SAN@M) with enhanced catalytic activity for reactive oxygen species (ROS) scavenging. The findings reveal its superior ability to preserve cardiomyocyte viability, reprogram macrophage phenotype, and restore immune homeostasis in acute myocardial infarction models, highlighting a significant advance in nanozyme-based therapies for oxidative stress and inflammation.

• JNJ-26854165 (Serdemetan): Precision Modulation of HDM2-p53

  2026-07-18

  Explore how JNJ-26854165 (Serdemetan) empowers precision cancer research as a potent HDM2 ubiquitin ligase antagonist and apoptosis inducer. This article presents a unique framework for integrating nuanced drug response metrics with advanced assay design.

450 records 10/30 page Previous Next First page 上5页 678910 下5页 Last page